Core C: CODEX Core
核心 C:CODEX 核心
基本信息
- 批准号:10704098
- 负责人:
- 金额:$ 33.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AntibodiesAntigensArchitectureBiological MarkersCell OntogenyCellsCellular StructuresConsultationsDataDetectionDevelopmentDiseaseEarly DiagnosisEnsureEpitheliumFrequenciesGenerationsGeneticGoalsHumanHuman ResourcesImageImmuneImmune EvasionImmune systemIndividualLaboratoriesLearningLinkMalignant neoplasm of pancreasMapsMethodsMonitorMusNeighborhoodsPancreasPopulationPublic HealthQuality ControlReagentResearchResearch PersonnelResourcesRetrievalRoleServicesSignal TransductionStainsStereotypingTimeTissue ProcurementsTissue imagingTissuesWorkcancer cellcancer therapycandidate identificationcell typecosteffective therapyhealth goalshuman tissueimmunoregulationin vivoindexingmouse modelpancreas imagingprogramssingle-cell RNA sequencingspatial relationshipstem cellstissue preparationtooltreatment responsetumortumor growthultrasound
项目摘要
ABSTRACT (Core C)
A central focus of our program is understanding the roles of specific cell types, including immune cell
populations, throughout the initiation, development and spread of PDAC in mouse models and in humans. A
key aspect of this effort is to define the frequency, spatial relationships and activation states of cell types within
tumors, and to learn how these parameters change over time and in response to therapy. Additionally, while
each project focuses on a different aspect of PDAC, a comprehensive understanding of the role of the epithelial
compartment and the immune system in PDAC will require simultaneous analysis of each of these cell types in
multiple tissues. To achieve these goals, we will use CO-Detection by indEXing (CODEX), a new method
generated by Dr. Nolan’s group at Stanford. CODEX will allow cytometric imaging of tissue sections with dozens
of antibodies. CODEX data from this Core can then be linked to complementary data from CyTOF and scRNASeq used in individual projects. The Specific Aims of Core C for human and mouse pancreas studies are:
1. Provide CODEX processing to investigators, including staining, imaging and quality control
2. Provide CODEX analysis, including antigen clustering, cell type annotation and neighborhood mapping
3. Develop new antibodies and reagents for CODEX in consultation with P01 investigators
4. Develop standard workflows for tissue procurement, processing, storage and retrieval in partnership
with the human pancreas tissue core (Core B).
Projects 1, 2 and 3 will specifically use the CODEX core platform for studies of both mouse and human tissues.
Core C will work closely with the Human Tissue Core B to ensure appropriate human tissue preparation to
support CODEX analysis. Thus, Core C will provide services technically difficult and not available in most
laboratories, materials not available commercially or impossible to obtain elsewhere, and services more reliably
and cost-effectively performed than if performed in an individual investigator’s laboratory. This CODEX Core
would be new, and unique at Stanford.
摘要(核心C)
我们计划的一个中心焦点是了解特定细胞类型的作用,包括免疫细胞
在小鼠模型和人类中,PDAC在整个启动、发展和传播过程中对群体的影响。一
这项工作的一个关键方面是定义细胞类型的频率、空间关系和激活状态,
肿瘤,并了解这些参数如何随着时间的推移和对治疗的反应而变化。此外,虽然
每个项目都侧重于PDAC的不同方面,全面了解上皮细胞的作用,
PDAC中的细胞区室和免疫系统将需要同时分析这些细胞类型中的每一种,
多种组织为了实现这些目标,我们将使用CO-Detection by indEXing(CODEX),一种新的方法
是由斯坦福大学的诺兰博士的研究小组产生的。CODEX将允许对组织切片进行细胞计数成像,
抗体。来自该核心的CODEX数据可以与来自CyTOF和scRNA的互补数据相关联在单个项目中使用的Seq。核心C用于人类和小鼠胰腺研究的具体目的是:
1.为研究者提供CODEX处理,包括染色、成像和质量控制
2.提供CODEX分析,包括抗原聚类、细胞类型注释和邻域作图
3.与P01研究者协商,为CODEX开发新的抗体和试剂
4.合作开发组织采购、处理、储存和检索的标准工作流程
与人胰腺组织核心(核心B)。
项目1、2和3将专门使用CODEX核心平台进行小鼠和人体组织的研究。
核心C将与人体组织核心B密切合作,以确保适当的人体组织制备,以
支持CODEX分析。因此,核心C将提供技术上困难的服务,并且在大多数情况下都不可用。
实验室,商业上无法获得或不可能在其他地方获得的材料,以及更可靠的服务
并且比在个体研究者的实验室中进行更具成本效益。CODEX核心
这在斯坦福大学将是一个全新的、独一无二的项目。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Seung K Kim其他文献
Seung K Kim的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Seung K Kim', 18)}}的其他基金
In vivo systems to discover mechanisms regulating human islet alpha cell function
体内系统发现调节人类胰岛α细胞功能的机制
- 批准号:
10623306 - 财政年份:2020
- 资助金额:
$ 33.36万 - 项目类别:
In vivo systems to discover mechanisms regulating human islet alpha cell function
体内系统发现调节人类胰岛α细胞功能的机制
- 批准号:
10228762 - 财政年份:2020
- 资助金额:
$ 33.36万 - 项目类别:
In vivo systems to discover mechanisms regulating human islet alpha cell function
体内系统发现调节人类胰岛α细胞功能的机制
- 批准号:
10441477 - 财政年份:2020
- 资助金额:
$ 33.36万 - 项目类别:
Therapeutic targeting of human islets with recombinant regulatory T cells
用重组调节性 T 细胞治疗人类胰岛
- 批准号:
10018894 - 财政年份:2019
- 资助金额:
$ 33.36万 - 项目类别:
Therapeutic targeting of human islets with recombinant regulatory T cells
用重组调节性 T 细胞治疗人类胰岛
- 批准号:
10450831 - 财政年份:2019
- 资助金额:
$ 33.36万 - 项目类别:
Therapeutic targeting of human islets with recombinant regulatory T cells
用重组调节性 T 细胞治疗人类胰岛
- 批准号:
9891726 - 财政年份:2019
- 资助金额:
$ 33.36万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 33.36万 - 项目类别:
Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 33.36万 - 项目类别:
Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 33.36万 - 项目类别:
Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 33.36万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 33.36万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 33.36万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 33.36万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 33.36万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 33.36万 - 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 33.36万 - 项目类别: